Published in Cancer Weekly, July 29th, 2008
"This study addresses the correlation between overall NK function and trastuzumab's clinical activity. Clinical and immunological responses were assessed in 26 patients receiving trastuzumab monotherapy as maintenance management after chemotherapy (8 mg/kg load and then...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly